Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: NOVARTIS PHARMACEUTICALS CORPORATION
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2017-09-14 to 2024-06-30
Current total value of award: $18874271.04
Description: THIS UNILATERAL MODIFICATION IS TO DEOBLIGATE CANCELLING FUNDS ON CLIN 00001.